Ready-to-use hiPSC-derived Cells Aid Workflow Optimization
AMSBIO introduces a range of hiPSC-derived cells, streamlining workflows by eliminating in-house differentiation, reducing prep time.
Read MorePosted by Chris Wolski | Feb 28, 2025 | Diagnostic Technologies |
AMSBIO introduces a range of hiPSC-derived cells, streamlining workflows by eliminating in-house differentiation, reducing prep time.
Read MorePosted by Chris Wolski | Feb 27, 2025 | Cancer |
Labcorp Plasma Complete is a ctDNA-based liquid biopsy test, enabling comprehensive genomic profiling from a simple blood draw.
Read MorePosted by Chris Wolski | Feb 27, 2025 | Covid 19 |
A virtual care study by UMass Chan Medical School is comparing the accuracy of at-home COVID-19 and flu tests to lab-based PCR tests.
Read MorePosted by Chris Wolski | Feb 26, 2025 | Covid 19 |
Aptitude Medical Systems has received FDA emergency use authorization for its Metrix COVID/Flu multiplex test.
Read MorePosted by Chris Wolski | Feb 25, 2025 | Kidney Disease |
Quest Diagnostics will acquire select assets of Fresenius Medical Care’s Spectra Laboratories, expanding its capabilities.
Read More